OABI
NASDAQ · Life Sciences Tools & Services
Omniab Inc
$5.07
+0.08 (+1.60%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+8.1% upside
Low Target
$3.95
Average Target
$5.48
High Target
$7.31
Current Price
$5.07
Current
$5.07
$5.07
Target
$5.48
$5.48
$3.95
$5.48 avg
$7.31
Scenario Analysis
Bear Case
$3.95
-22.1%
Low target
Base Case
$5.48
+8.1%
Avg target
Bull Case
$7.31
+44.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$5.43
-6.6% from high
52-Week Low
$1.30
+290.0% from low
Target vs 52W High
$5.48
+0.9% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -43.6% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -26.1% |
| A | Strong Buy | 30 | 77% | $64.69 | -61.4% |
| WAT | Buy | 31 | 65% | $189.60 | -55.4% |
| IQV | Strong Buy | 28 | 82% | $82.96 | -67.9% |
| ILMN | Buy | 28 | 57% | $169.36 | -38.0% |
| MTD | Hold | 19 | 53% | $170.43 | -88.5% |
| WST | Strong Buy | 23 | 91% | $136.24 | -62.7% |